{
  "folder": "IC-198",
  "content": "{{knowledge objective\n|Identifiant=OIC-198-16-B\n|Item_parent=Microcrystalline arthropathies\n|Item_parent_short=Microcrystalline arthropathies\n|Rank=B\n|Title=Knowing the risk of excess mortality in untreated gout\n|Description=U-shaped curve\n|Heading=Monitoring and/or prognosis\n|Contributors=\n|Order=16}}\n- Gout must be treated in view of its associated cardiovascular mortality.\n\n- However, hypouricaemia also carries a risk of increased mortality.",
  "question": {
    "properties": {
      "question": {
        "title": "What is a potential risk associated with untreated hypouricemia in patients with gout?",
        "description": "A U-shaped curve of mortality risk",
        "type": "string"
      },
      "option_a": {
        "title": "Increased mortality due to cardiovascular disease",
        "description": "A well-established risk factor for cardiovascular disease",
        "type": "string"
      },
      "option_b": {
        "title": "Increased mortality due to renal failure",
        "description": "A potential complication of untreated hypouricemia",
        "type": "string"
      },
      "option_c": {
        "title": "Increased mortality due to both cardiovascular and renal disease",
        "description": "A potential risk associated with untreated hypouricemia",
        "type": "string"
      },
      "option_d": {
        "title": "Decreased mortality due to improved treatment outcomes",
        "description": "A benefit of treating hypouricemia in patients with gout",
        "type": "string"
      },
      "correct_option": {
        "title": "C",
        "description": "C"
      }
    },
    "required": [
      "question",
      "option_a",
      "option_b",
      "option_c",
      "option_d",
      "correct_option"
    ]
  }
}